Clinical Trial Update: Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants [Phase 3]

View source ↗

Summary

Pfizer's Phase 3 trial of NeisVac-C in healthy infants evaluated whether concomitant Hepatitis B, inactivated polio and acellular pertussis vaccines interfere i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• NeisVac-C (Meningococcal conjugate vaccine against Neisseria meningitidis group C)

Snippet

Sponsor: Pfizer | Conditions: Meningitis, Meningococcal | Phase 3 | Status: COMPLETED